The HIV-derived protein Vpr 52-96 has anti-glioma activity in vitro and in vivo - Kübler, Jens; Kirschner, Stefanie; Hartmann, Linda; Welzel, Grit; Engelhardt, Maren; Herskind, Carsten; Veldwijk, Marlon Romano; Schultz, Christian; Felix, Manuela; Glatting, Gerhard; Maier, Patrick; Wenz, Frederik; et al. (OncoTarget, 2016)
Gesehen am 08.07.2019